[1] Clara M, Strenn B, Gans O, et al. Removal of selected pharmaceuticals,fragrances and endocrine disrupting compounds in a membranebioreactor and conventional wastewater treatment plants[J]. WaterResearch. 2005, 39(19): 4 797-4 807.
[2] Jack N. GE ZeeWeed. MBR technology for pharmaceutical wastewatertreatment[J]. Membrane Technology, 2006(9): 7-9.
[3] Wisniewski C, Grasmick A. Floc size distribution in membranebioreactor and consequences for membrane fouling[J]. Colloids andSurfaces A: Physicochemical and Engineering Aspects, 1998, 138(2-3): 403-411.
[4] Defrance L, Jaffrin M Y. Comparison between filtration at fixedtrans -membrane pressure and fixed permeate flux: application to amembrane bioreactor used for wastewater treatment[J]. Journal ofMembrane Science, 1999, 152(2): 203-210.
[5] Xing C, Tardieu E, Qian Y, et al. Ultra filtration membrane bioreactorfor urban wastewater reclamation[J]. Journal of Membrane Science,2000, 177(1-2): 73-82.
[6] Bouhabila E, AimR B, Buisson H. Fouling characterization in membranebioreactor[J]. Separation Purification and Technology, 2001,22(5): 123-132.
[7] 顾国维, 何义亮. 膜生物反应器———在污水处理中的研究和应用[M]. 北京: 化学工业出版社, 2002: 124.
[8] Katsuki K, Hiroe H, Yoshimasa W. Removal of pharmaceutical compoundsby submerged membrane bioreactors (MBRs)[J]. Desalination,2005, 178(1-3): 135-140.
[9] 相震, 陈淑娟, 王连军, 等. 膜生物反应器联合工艺处理合成制药废水的中试[J]. 环境科学与技术, 2005, 28(4): 99-100.
[10] 白晓慧, 陈英旭. 一体式膜生物反应器处理医药化工废水的试验[J]. 环境污染与防治, 2000, 22(6): 19-21.
[11] 国家环境保护总局. 水和废水监测分析方法[M]. 第4 版. 北京:中国环境科学出版社, 2002: 211-213.
[12] Defrance L, Jaffrin M Y, Bharat G, et al. Contribution of variousconstituents of activated sludge to membrane bioreactor fouling[J].Bioresource Technology, 2000, 73(2): 105-112.
[13] Hong S P, Bae T H, Tak T M, et al. Fouling control in activatedsludge submerged hollowfiber membrane bioreactors[J]. Desalination,2002, 143(3): 219-228.
[14] 朱振中, 周艳, 李秀芬, 等. 好氧颗粒污泥膜生物反应器的运行特性[J]. 环境科学, 2006, 27(1): 57-62. |